Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03869840 · ClinicalTrials.gov registry record
Accuracy of Detection of Methemoglobin With Pulse Oximetry
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 13
- Enrollment target
NCT03869840: Completed study, sponsored by Nonin Medical.
NCT03869840 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03869840 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The non-invasive measurement of dysfunctional hemoglobins allows physicians to monitor levels in affected individuals without requiring blood samples or laboratory testing. Nonin Medical Inc, has recently developed a multi-wavelength device that measures carboxyhemoglobin and methemoglobin non-invasively. The primary objective of this study is to validate %MetHb and SpO2 accuracy performance of the study device. Evaluations will be for the range of 0 to 15% MetHb with 95-100% SaO2 as assessed by CO-oximetry, and 0-15% MetHb accuracy under conditions of elevated HHb (SaO2 80-100%) as assessed by CO-oximetry, and SpO2 with 80-100% SaO2 during elevated MetHb as assessed by CO-oximetry.
Primary Outcome
Validate %MetHb accuracy over the range of 0-15% MetHb with SaO2 greater than 95% as assessed by CO-oximetry
Interventions
- DEVICE Sensor to spot check blood levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2019-03-29 |
What the finished NCT03869840 record still lists
NCT03869840 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sensor to spot check blood levels is the first listed.
NCT03869840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03869840 about?
NCT03869840 is a clinical study titled "Accuracy of Detection of Methemoglobin With Pulse Oximetry". The non-invasive measurement of dysfunctional hemoglobins allows physicians to monitor levels in affected individuals without requiring blood samples or laboratory testing. Nonin Medical Inc, has recently developed a multi-wavelength device that measures carboxyhemoglobin and methemoglobin non-invas...
What is the current status of trial NCT03869840?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2019-03-26. Estimated completion is 2019-03-29.
What interventions are being tested in trial NCT03869840?
The interventions under investigation include: Sensor to spot check blood levels (DEVICE).
Who is sponsoring clinical trial NCT03869840?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI